BioAffinity Stock Based Compensation from 2010 to 2024

BIAFW Stock  USD 0.45  0.08  21.62%   
BioAffinity Technologies Stock Based Compensation yearly trend continues to be fairly stable with very little volatility. Stock Based Compensation is likely to outpace its year average in 2024. Stock Based Compensation is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. View All Fundamentals
 
Stock Based Compensation  
First Reported
2010-12-31
Previous Quarter
748.8 K
Current Value
786.3 K
Quarterly Volatility
189.8 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check BioAffinity Technologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioAffinity Technologies' main balance sheet or income statement drivers, such as Depreciation And Amortization of 262.1 K, Interest Expense of 35.3 K or Gross Profit of 831.2 K, as well as many indicators such as Price To Sales Ratio of 4.82, Dividend Yield of 0.0 or PTB Ratio of 2.78. BioAffinity financial statements analysis is a perfect complement when working with BioAffinity Technologies Valuation or Volatility modules.
  
Check out the analysis of BioAffinity Technologies Correlation against competitors.

Latest BioAffinity Technologies' Stock Based Compensation Growth Pattern

Below is the plot of the Stock Based Compensation of bioAffinity Technologies Warrant over the last few years. It is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. BioAffinity Technologies' Stock Based Compensation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BioAffinity Technologies' overall financial position and show how it may be relating to other accounts over time.
Stock Based Compensation10 Years Trend
Slightly volatile
   Stock Based Compensation   
       Timeline  

BioAffinity Stock Based Compensation Regression Statistics

Arithmetic Mean323,983
Geometric Mean277,306
Coefficient Of Variation58.59
Mean Deviation118,283
Median275,732
Standard Deviation189,818
Sample Variance36B
Range743.3K
R-Value0.45
Mean Square Error31B
R-Squared0.20
Significance0.09
Slope19,092
Total Sum of Squares504.4B

BioAffinity Stock Based Compensation History

2024786.3 K
2023748.8 K
2022248.6 K
202143 K

Other Fundumenentals of BioAffinity Technologies

BioAffinity Technologies Stock Based Compensation component correlations

0.78-0.85-0.80.810.51-0.330.95-0.570.950.810.98-0.910.950.98-0.42-0.42
0.78-0.96-0.520.50.5-0.80.74-0.950.760.40.8-0.820.770.82-0.47-0.47
-0.85-0.960.49-0.47-0.330.73-0.870.86-0.76-0.44-0.850.79-0.76-0.870.310.31
-0.8-0.520.49-0.91-0.84-0.08-0.670.32-0.85-0.87-0.860.9-0.88-0.830.80.8
0.810.5-0.47-0.910.79-0.020.62-0.330.930.890.8-0.850.930.78-0.63-0.63
0.510.5-0.33-0.840.79-0.10.29-0.460.690.590.6-0.790.730.58-0.95-0.95
-0.33-0.80.73-0.08-0.02-0.1-0.320.91-0.320.12-0.30.33-0.31-0.340.040.04
0.950.74-0.87-0.670.620.29-0.32-0.520.820.70.94-0.810.820.94-0.27-0.27
-0.57-0.950.860.32-0.33-0.460.91-0.52-0.6-0.16-0.60.67-0.61-0.630.440.44
0.950.76-0.76-0.850.930.69-0.320.82-0.60.830.93-0.941.00.93-0.55-0.55
0.810.4-0.44-0.870.890.590.120.7-0.160.830.78-0.740.820.75-0.47-0.47
0.980.8-0.85-0.860.80.6-0.30.94-0.60.930.78-0.960.941.0-0.56-0.56
-0.91-0.820.790.9-0.85-0.790.33-0.810.67-0.94-0.74-0.96-0.96-0.960.740.74
0.950.77-0.76-0.880.930.73-0.310.82-0.611.00.820.94-0.960.94-0.6-0.6
0.980.82-0.87-0.830.780.58-0.340.94-0.630.930.751.0-0.960.94-0.54-0.54
-0.42-0.470.310.8-0.63-0.950.04-0.270.44-0.55-0.47-0.560.74-0.6-0.541.0
-0.42-0.470.310.8-0.63-0.950.04-0.270.44-0.55-0.47-0.560.74-0.6-0.541.0
Click cells to compare fundamentals

About BioAffinity Technologies Financial Statements

BioAffinity Technologies investors use historical fundamental indicators, such as BioAffinity Technologies' Stock Based Compensation, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in BioAffinity Technologies. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Stock Based Compensation748.8 K786.3 K
Stock Based Compensation To Revenue 0.30  0.28 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for BioAffinity Stock Analysis

When running BioAffinity Technologies' price analysis, check to measure BioAffinity Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioAffinity Technologies is operating at the current time. Most of BioAffinity Technologies' value examination focuses on studying past and present price action to predict the probability of BioAffinity Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioAffinity Technologies' price. Additionally, you may evaluate how the addition of BioAffinity Technologies to your portfolios can decrease your overall portfolio volatility.